Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways

Oncotarget

Volumn 7, Issue 24, 2016, Pages 36842-36853

  Lee, Yeo Song ^a   Kim, So Young ^a   Song, Su Jeong ^a   Hong, Hye Kyung ^a   Lee, Yura ^a   Oh, Bo Young ^b   Lee, Woo Yong ^b,c   Cho, Yong Beom ^b,c  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

CCL7; CCR3; Colon cancer; ERK JNK signaling; Metastasis

Indexed keywords

CHEMOKINE RECEPTOR CCR3; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 3; STRESS ACTIVATED PROTEIN KINASE; CCL7 PROTEIN, HUMAN; CCR3 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; COLON TUMOR; HCT 116 CELL LINE; HUMAN; MAPK SIGNALING; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; RECEPTOR CROSS-TALK; TUMOR INVASION; XENOGRAFT;

ANIMALS; CHEMOKINE CCL7; COLONIC NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; HCT116 CELLS; HETEROGRAFTS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; RECEPTOR CROSS-TALK; RECEPTORS, CCR3;

EID: 84978123669     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9209     Document Type: Article

References (36)

1. Lee JM, Dedhar S, Kalluri R and Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. The Journal of cell biology. 2006; 172:973-981.
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nature reviews Cancer. 2002; 2:442-454.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61:69-90.
4. Lee JH, Cho YS, Lee JY, Kook MC, Park JW, Nam BH and Bae JM. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Ann Surg. 2009; 249:933-941.
5. Zlotnik A. Chemokines and cancer. Int J Cancer. 2006; 119:2026-2029.
6. Balkwill F. Cancer and the chemokine network. Nature reviews Cancer. 2004; 4:540-550.
7. Jung DW, Che ZM, Kim J, Kim K, Kim KY, Williams D and Kim J. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer. 2010; 127:332-344.
8. Liu Y, Ji R, Li J, Gu Q, Zhao X, Sun T, Wang J, Li J, Du Q and Sun B. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010; 29:16.
9. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, Minty A and Baggiolini M. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J Exp Med. 1994; 179:751-756.
10. Opdenakker G, Froyen G, Fiten P, Proost P and Van Damme J. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun. 1993; 191:535-542.
11. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B and Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol. 1995; 25:64-68.
12. Menten P, Proost P, Struyf S, Van Coillie E, Put W, Lenaerts JP, Conings R, Jaspar JM, De Groote D, Billiau A, Opdenakker G and Van Damme J. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur J Immunol. 1999; 29:678-685.
13. Power CA, Clemetson JM, Clemetson KJ and Wells TN. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine. 1995; 7:479-482.
14. Zhu F, Liu P, Li J and Zhang Y. Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression. Oncology reports. 2014; 31:2049-2054.
15. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF and Wu CM. CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis. World J Gastroenterol. 2012; 18:1249-1256.
16. Cho YB, Lee WY, Choi SJ, Kim J, Hong HK, Kim SH, Choi YL, Kim HC, Yun SH, Chun HK and Lee KU. CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncology reports. 2012; 28:689-694.
17. Hu JY, Li GC, Wang WM, Zhu JG, Li YF, Zhou GH and Sun QB. Transfection of colorectal cancer cells with chemokine MCP-3 (monocyte chemotactic protein-3) gene retards tumor growth and inhibits tumor metastasis. World J Gastroenterol. 2002; 8:1067-1072.
18. Liu SQ, Saijo K, Todoroki T and Ohno T. Induction of human autologous cytotoxic T lymphocytes on formalinfixed and paraffin-embedded tumour sections. Nat Med. 1995; 1:267-271.
19. Kitamura T and Taketo MM. Keeping out the bad guys: gateway to cellular target therapy. Cancer research. 2007; 67:10099-10102.
20. Zlotnik A, Morales J and Hedrick JA. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol. 1999; 19:1-47.
21. Johrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Holtl L, Bartsch G, Greil R and Thurnher M. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res. 2005; 11:2459-2465.
22. Lee YJ, Kim DH, Lee SH, Nam HS, Roh MR and Cho MK. Chemokine Receptor CCR3 Expression in Malignant Cutaneous Tumors. Ann Dermatol. 2010; 22:412-417.
23. Kouno J, Nagai H, Nagahata T, Onda M, Yamaguchi H, Adachi K, Takahashi H, Teramoto A and Emi M. Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth. J Neurooncol. 2004; 70:301-307.
24. Hou SX, Zheng Z, Chen X and Perrimon N. The Jak/STAT pathway in model organisms: emerging roles in cell movement. Dev Cell. 2002; 3:765-778.
25. Schindler CW. Series introduction. JAK-STAT signaling in human disease. The Journal of clinical investigation. 2002; 109:1133-1137.
26. Luo C and Laaja P. Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs. Drug Discov Today. 2004; 9:268-275.
27. Blume-Jensen P and Hunter T. Oncogenic kinase signalling. Nature. 2001; 411:355-365.
28. Osaki M, Oshimura M and Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004; 9:667-676.
29. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C and Cobb MH. MAP kinases. Chem Rev. 2001; 101:2449-2476.
30. Tanoue T and Nishida E. Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol Ther. 2002; 93:193-202.
31. Dent P, Yacoub A, Fisher PB, Hagan MP and Grant S. MAPK pathways in radiation responses. Oncogene. 2003; 22:5885-5896.
32. Yang SH, Sharrocks AD and Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene. 2003; 320:3-21.
33. Maddaluno M, Di Lauro M, Di Pascale A, Santamaria R, Guglielmotti A, Grassia G and Ialenti A. Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis. 2011; 217:113-119.
34. Fu Y, Ma D, Liu Y, Li H, Chi J, Liu W, Lin F, Hu J, Zhang X, Zhu M, Zhao Y and Yin X. Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway. Laboratory investigation; a journal of technical methods and pathology. 2015; 95:1246-1257.
35. Laurent V, Guerard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, Zaidi F, Majed B, Garandeau D, Socrier Y, Golzio M, Cadoudal T, Chaoui K, Dray C, Monsarrat B, Schiltz O, et al. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nature communications. 2016; 7:10230.
36. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S and Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer cell. 2007; 11:447-460.